Imaging-based Diagnostic and Therapeutic Strategies for Prostate Cancer in the Coming Decades

被引：8

作者：

Padhani, Anwar R. ^{[1
]}

Schoots, Ivo G. ^{[2
,3
]}

机构：

[1] Mt Vernon Canc Ctr, Paul Strickland Scanner Ctr, Rickmansworth Rd, Northwood HA6 2RN, England

[2] Erasmus Univ, Dept Radiol & Nucl Med, Med Ctr, Rotterdam, Netherlands

[3] Netherlands Canc Inst, Dept Radiol, Amsterdam, Netherlands

来源：

RADIOLOGY | 2023年 / 307卷 / 05期

关键词：

MRI; RECOMMENDATIONS; BIOPSY; PSA;

D O I：

10.1148/radiol.222990

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页数：7

共 37 条

[1] Artificial Intelligence-assisted Prostate Cancer Diagnosis: Radiologic-Pathologic Correlation
Alcala Mata, Lidia
Antonio Retamero, Juan
Gupta, Rajan T.
Garcia Figueras, Roberto
Luna, Antonio
[J]. RADIOGRAPHICS, 2021, 41 (06) : 1676 - 1697
[2] Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway
Barrett, Tristan
de Rooij, Maarten
Giganti, Francesco
Allen, Clare
Barentsz, Jelle O.
Padhani, Anwar R.
[J]. NATURE REVIEWS UROLOGY, 2023, 20 (01) : 9 - 22
[3] Update of the Standard Operating Procedure on the Use of Multiparametric Magnetic Resonance Imaging for the Diagnosis, Staging and Management of Prostate Cancer
Bjurlin, Marc A.
Carroll, Peter R.
Eggener, Scott
Fulgham, Pat F.
Margolis, Daniel J.
Pinto, Peter A.
Rosenkrantz, Andrew B.
Rubenstein, Jonathan N.
Rukstalis, Daniel B.
Taneja, Samir S.
Turkbey, Baris
[J]. JOURNAL OF UROLOGY, 2020, 203 (04) : 706 - 712
[4] [Anonymous], 2020, CA Cancer J Clin, V70, P313, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[5] The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Cooperberg, Matthew R.
Erho, Nicholas
Chan, June M.
Feng, Felix Y.
Fishbane, Nick
Zhao, Shuang G.
Simko, Jeffry P.
Cowan, Janet E.
Lehrer, Jonathan
Alshalalfa, Mohammed
Kolisnik, Tyler
Chelliserry, Jijumon
Margrave, Jennifer
Aranes, Maria
du Plessis, Marguerite
Buerki, Christine
Tenggara, Imelda
Davicioni, Elai
Carroll, Peter R.
[J]. EUROPEAN UROLOGY, 2018, 74 (04) : 444 - 452
[6] Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial priorities
Dee, Edward Christopher
Nezolosky, Michelle D.
Chipidza, Fallon E.
Arega, Melaku A.
Butler, Santino S.
Sha, Sybil T.
Mahal, Brandon A.
Nguyen, Paul L.
Yang, David D.
Muralidhar, Vinayak
[J]. PROSTATE, 2020, 80 (13) : 1128 - 1133
[7] Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing
Donners, Ricardo
Figueiredo, Ines
Tunariu, Nina
Blackledge, Matthew
Koh, Dow-Mu
de la Maza, Maria de los Dolores Fenor
Chandran, Khobe
de Bono, Johann S.
Fotiadis, Nicos
[J]. EUROPEAN RADIOLOGY, 2022, 32 (07) : 4647 - 4656
[8] Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis
Drost, Frank-Jan H.
Osses, Daniel
Nieboer, Daan
Bangma, Chris H.
Steyerberg, Ewout W.
Roobol, Monique J.
Schoots, Ivo G.
[J]. EUROPEAN UROLOGY, 2020, 77 (01) : 78 - 94
[9] Population-Based Prostate Cancer Screening With Magnetic Resonance Imaging or Ultrasonography The IP1-PROSTAGRAM Study
Eldred-Evans, David
Burak, Paula
Connor, Martin J.
Day, Emily
Evans, Martin
Fiorentino, Francesca
Gammon, Martin
Hosking-Jervis, Feargus
Klimowska-Nassar, Natalia
McGuire, William
Padhani, Anwar R.
Prevost, A. Toby
Price, Derek
Sokhi, Heminder
Tam, Henry
Winkler, Mathias
Ahmed, Hashim U.
[J]. JAMA ONCOLOGY, 2021, 7 (03) : 395 - 402
[10] Is Grade Group 1 (Gleason score 3+3=6) adenocarcinoma of the prostate really cancer?
Epstein, Jonathan I.
[J]. CURRENT OPINION IN UROLOGY, 2022, 32 (01) : 91 - 95

← 1 2 3 4 →